The Sensex has more than doubled from its pandemic lows hit March 2020, powered by millions of first-time investors, willing to buy riskier...

SBI board will consider raising additional tier-1 capital on July 1.

Deutsche Bank has maintained a 'buy' rating on ICICI Prudential Life Insurance Company.

“The share price fairly reflects upside from Copaxone 40 mg and approval remains a hurdle,“ said Nimish Mehta, founder director at Research...

The drug in focus is the generic version of Nexium, a heartburn pill, which has earned over $5.5 billion for the owner AstraZeneca so far.

The second edition of 'Couture Cabanas' is all set to be unveiled at rooftop destination Asilo at St.Regis Hotel in Mumbai on November 27.

The decision by the Supreme Court comes at a time when Teva is switching its daily version of Copaxone to twice a week version.

Mumbai-based generics drugmaker Wockhardt on Tuesday agreed to pay back the money it owes to holders of its FCCBs in five instalments endin...

The proposed penalty on Ranbaxy reported by Fortune magazine is more than double of what the industry has been speculating.

Infy stock price target is being cut as investors ponder the co's future beyond its founders and its ability to survive in a competitive wo...

Sun Pharmaceutical will bring its product development skills to the table, while Merck will help with market presence.

Forget its financial and legal woes, Habil Khorakiwala wants the world to notice that Wockhardt is on the road to recovery.

Forget its financial and legal woes, Habil Khorakiwala wants the world to notice that Wockhardt is on the road to recovery.

Investors and experts tracking the co are hoping that the new mgmt would provide more clarity by disclosing quarterly accounts of MSatyam.

SAP management team held their first-ever Board week in India, reiterating their commitment to its customers, employees, partners and their...

Recent drug outlicensing deals by Indian pharma companies have created much hope for research initiatives in the country.